Clinical Trials
16 trialsNCT03627988 2026-05-22
MARTA
Institut Claudius Regaud
Phase 2 Completed
NCT07590570 2026-05-15
The Association of Lunula Status With the Efficacy and Safety of Neoadjuvant Therapy in Breast Cancer
RenJi Hospital
Active not recruiting
NCT07283718 2026-05-13
The Association Between Axillary Lymph Node Metastasis Patterns and Breast Cancer Prognosis
RenJi Hospital
Active not recruiting
NCT07584213 2026-05-13
The Association Between Blood Routine Parameters and Breast Cancer Prognosis
RenJi Hospital
Active not recruiting
NCT06695039 2025-12-02
Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in ER-positive Breast Cancer
Asan Medical Center
Phase 2 Completed
NCT06958991 2025-11-25
CHiB
University of Fribourg
Phase NA Recruiting
NCT05910398 2025-11-18
CORINNE-PI
RenJi Hospital
Phase 3 Recruiting
NCT06583655 2025-07-31
Precision Regional Node Irradiation for Sentinel Node-positive Breast Cancer
Ruijin Hospital
Phase NA Active not recruiting
NCT06686459 2025-07-01
BC-AIO
Sun Yat-sen University
Phase NA Recruiting
NCT06781281 2025-06-23
NabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer.
Henan Cancer Hospital
Recruiting
NCT06790264 2025-01-27
FAPI-PET
European Institute of Oncology
Phase NA Recruiting
NCT06716073 2024-12-04
Long-Term Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase NA Recruiting
NCT05505357 2024-02-28
OPTIMIST
Seoul National University Hospital
Phase NA Recruiting
NCT03664895 2023-12-04
Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial)
Seoul National University Hospital
Phase 3 Unknown
NCT04398914 2022-03-31
Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
Shanghai Jiao Tong University School of Medicine
Phase 2 Active not recruiting
NCT03669705 2018-09-13
No Axillary Surgery for Early Breast Cancer.
Lund University
Completed